331 results on '"Hickman, Peter E."'
Search Results
52. Using a thyroid disease-free population to define the reference interval for TSH and free T4 on the Abbott Architect analyser
53. Is It Time to Do Away With the 99th Percentile for Cardiac Troponin in the Diagnosis of Acute Coronary Syndrome and the Assessment of Cardiac Risk?
54. Uncertainty of Measurement: What it is and What it Should Be
55. Decision limits and the reporting of cardiac troponin: Meeting the needs of both the cardiologist and the ED physician
56. Free Radical Scavengers Improve Liver Function but Not Morphological Changes Induced by Reperfusion Injury
57. Use of Observed Within-Person Variation of Cardiac Troponin in Emergency Department Patients for Determination of Biological Variation and Percentage and Absolute Reference Change Values
58. Is It Time to Do Away With the 99th Percentile for Cardiac Troponin in the Diagnosis of Acute Coronary Syndrome and the Assessment of Cardiac Risk?
59. Effects of Changes in Adiposity and Physical Activity on Preadolescent Insulin Resistance: The Australian LOOK Longitudinal Study
60. Effect of population selection on 99th percentile values for a high sensitivity cardiac troponin I and T assays
61. Opportunistic pathology-based screening for diabetes
62. The distribution of cardiac troponin I in a population of healthy children: Lessons for adults
63. Longitudinal Studies of Cardiac Troponin I in a Large Cohort of Healthy Children
64. Effects of Changes in Adiposity and Physical Activity on Preadolescent Insulin Resistance: The Australian LOOK Longitudinal Study
65. APPLICATION OF AN IMMUNORADIOMETRIC ASSAY FOR THYROTROPHIN IN EVALUATION OF THYROIDAL AND NONTHYROIDAL DISEASE STATES
66. Troponin measurement and the new assays: how low can we go?
67. What Criteria Should Be Used to Assess Troponin Assays?
68. Contrasting longitudinal and cross-sectional relationships between insulin resistance and percentage of body fat, fitness, and physical activity in childrenâthe LOOK study
69. The lifestyle of our kids (LOOK) project: Outline of methods
70. Over-reporting significant figures—a significant problem?
71. Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients
72. Total intra-individual variation in sweat sodium and chloride concentrations for the diagnosis of cystic fibrosis
73. Reporting of cardiac troponin — Problems with the 99th population percentile
74. Newer cardiac troponin I assays have similar performance to troponin T in patients with end-stage renal disease
75. Free Radical Scavengers Improve Liver Function but Not Morphological Changes Induced by Reperfusion Injury.
76. Decision limits and the reporting of cardiac troponin: Meeting the needs of both the cardiologist and the ED physician.
77. Correction and reporting of potassium results in haemolysed samples
78. Changes in troponin kits preclude meaningful collection of data on population 99th percentiles
79. Objective determination of appropriate reporting intervals
80. Area-Under-the-Curve Monitoring of Prednisolone for Dose Optimization in a Stable Renal Transplant Population
81. Quality Assessment of Interpretative Commenting in Clinical Chemistry
82. Practical Considerations for the Measurement of Free Light Chains in Serum
83. Use of chloride gradient for rapid identification of CSF leaks
84. Intravenous immunoglobulin as a source of passively acquired thyroid autoantibodies
85. Letters to the Editor: Sensitivity and specificity - is your test reliable?
86. Reporting of Cardiac Troponin Concentrations
87. Introduction to “Screening for Disease”
88. Thyroid stimulating hormone secretion is a dynamic process
89. Why there is discordance in reported decision thresholds for transferrin saturation when screening for hereditary hemochromatosis
90. Confidence Intervals and Free Prostate-specific Antigen
91. Longitudinal Study of Bone Turnover after Acute Spinal Cord Injury1
92. Clinical chemistry and post-liver-transplant monitoring
93. An Optimized Model for Rat Liver Perfusion Studies
94. The Use of the Lidocaine-Monoethylglycinexylidide Test in the Liver Transplant Recipient
95. Heresy trial
96. Altered endogenous growth hormone secretory kinetics and diurnal GH-binding protein profiles in adults with chronic liver disease
97. Simple Procedures Can Markedly Enhance Automated Immunoassay Performance
98. GAMMA GLUTAMYL TRANSFERASE AS A MARKER OF LIVER TRANSPLANT REJECTION
99. USE OF MONOETHYLGLYCINEXYLIDIDE AS A LIVER FUNCTION TEST IN THE LIVER TRANSPLANT RECIPIENT1
100. The Authors’ Reply
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.